Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 75A50120R00053_
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50121P00003 Federal contract award
- Awardee
- Monogram Biosciences, Inc.
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- South San Francisco CA 94080 USA
Notice details come from SAM.gov. Updated .
About this opportunity
The Biomedical Advanced Research and Development Authority within the Department of Health and Human Services published a Limited/Sole Source Justification Notice to establish a high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and test human serum samples through an undisclosed vendor. Citing the COVID-19 pandemic as an unusual and compelling urgency, the notice provides justification under $30 billion awarded for COVID-19 response and recovery efforts through December 2021. BARDA issued a sole source contract on October 26, 2020 to an unknown vendor for an undisclosed amount to develop the immunoassay capability and conduct serum testing in support of COVID-19 research and development, supplies, equipment, information technology, construction services, and architect-engineer services needs.
Notice text
The Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human
Services (HHS) seeks to establish a high throughput SARS-CoV-2 high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples.
Awarded contract 75A50121P00003 to unknown vendor for unknown amount on 2020-10-26.
Files
| File | Type | Posted |
|---|---|---|
| Posted Class J and A_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Limited / Sole Source Justification | |
| Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples | Limited / Sole Source Justification | |
| Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples | Award Notice | |
| Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity